Weiping Shao

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

Frederick E. Dewey, Viktoria Gusarova, Richard L. Dunbar et al. · New England Journal of Medicine · 2017 · 875 citations · Full text

Medicine, Genetics, Molecular Genetics +15

Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study

Sumathi Sivapalasingam, Rabih Slim, Romana Hosain et al. · The Lancet Infectious Diseases · 2018 · 85 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma

Julio C. Chávez, Francine M. Foss, Basem M. William et al. · Clinical Cancer Research · 2023 · 33 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard <u>(Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity &amp; Technologies; Biotherapeutics Immunogenicity &amp; Risk Assessment; ADA/NAb Assay/Reporting Harmonization)

Johanna Mora, Rachel Palmer, Leslie Wagner et al. · Bioanalysis · 2024 · 20 citations · Full text

Pharmacy, Biomedical Sciences, Immunology +17

Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-C

Beth A. Taylor, Gregory A. Panza, Linda S. Pescatello et al. · Journal of Lipids · 2014 · 11 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15